Charmacy Pharmaceutical Co Ltd
HKEX:2289
Charmacy Pharmaceutical Co Ltd
Income from Continuing Operations
Charmacy Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Charmacy Pharmaceutical Co Ltd
HKEX:2289
|
Income from Continuing Operations
¥51.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Income from Continuing Operations
¥15B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Income from Continuing Operations
¥5.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Income from Continuing Operations
¥2.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
16%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Income from Continuing Operations
¥2.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
18%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Income from Continuing Operations
¥2.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
14%
|
See Also
What is Charmacy Pharmaceutical Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
51.3m
CNY
Based on the financial report for Dec 31, 2023, Charmacy Pharmaceutical Co Ltd's Income from Continuing Operations amounts to 51.3m CNY.
What is Charmacy Pharmaceutical Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
3%
Over the last year, the Income from Continuing Operations growth was -43%. The average annual Income from Continuing Operations growth rates for Charmacy Pharmaceutical Co Ltd have been 8% over the past three years , 3% over the past five years .